Rabbit Recombinant Monoclonal HCN3 antibody. Carrier free. Suitable for IP, WB and reacts with Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Rat | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Hyperpolarization-activated ion channel that are permeable to sodium and potassium ions, with an about 3:1 preference for potassium ions (PubMed:16043489). Contributes to the native pacemaker currents in heart (If) and in neurons (Ih). In particular, plays a pivotal role in maintaining excitability and promoting rhythmic burst firing within hypothalamic nuclei. Exerts a significant influence on the configuration of the cardiac action potential waveform. Does not appear to play a prominent role in the processing of acute, neuropathic, or inflammatory pain (By similarity).
KIAA1535, HCN3, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3
Rabbit Recombinant Monoclonal HCN3 antibody. Carrier free. Suitable for IP, WB and reacts with Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
ab251107 is the carrier-free version of Anti-HCN3 antibody [EPR13494(2)] ab192025.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
The Hyperpolarization-activated Cyclic Nucleotide-gated channel 3 (HCN3) also known as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 is a protein that forms ion channels. These channels facilitate the flow of sodium and potassium ions across the cell membrane which is essential for maintaining the electrical activity in cells. HCN3 has a molecular mass of approximately 97 kDa and is expressed in various tissues including the brain and heart. Its role in creating the 'funny current' makes it important for electrical rhythms in these tissues.
HCN3 channels contribute to pacemaker activities in neurons and cardiac cells regulating heartbeat and neural firing. HCN3 does not operate in isolation; it can be part of larger channel complexes influencing the excitability of cells. These channels act by responding to membrane hyperpolarization opening to allow ion flow that modulates cell activity and therefore impacts processes like synaptic transmission and cardio-excitatory responses.
HCN3 channels integrate into signal transduction pathways involving cyclic nucleotides specifically the cAMP pathway. They interact with other hyperpolarization-activated cyclic nucleotide-gated channels like HCN1 and HCN2 which help refine electrical signaling. HCN3's involvement in the regulation of neural excitability links it to pathways governing neurotransmitter release and heart rate modulation.
HCN3 potentially relates to epilepsy and cardiac arrhythmias. Aberrant HCN3 channel function can disrupt electrical signaling contributing to pathogenesis in these conditions. Interactions with other ion channels such as HCN2 may amplify disturbances in neural firing and cardiac pacing. Understanding HCN3’s functional mechanics offers insight into its role in disease manifestation and could guide therapeutic targeting.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-HCN3 antibody [EPR13494(2)] ab192025, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-HCN3 antibody [EPR13494(2)] (Anti-HCN3 antibody [EPR13494(2)] ab192025) at 0.511 µg/mL
Lane 1: Mouse brain tissue lysate at 20 µg
Lane 2: Rat Brain Tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 0.05 µg/mL
Predicted band size: 86 kDa
Observed band size: 100 kDa
This data was developed using Anti-HCN3 antibody [EPR13494(2)] ab192025, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-HCN3 antibody [EPR13494(2)] (Anti-HCN3 antibody [EPR13494(2)] ab192025) at 1/10000 dilution
Lane 1: Human cerebellum lysate at 20 µg
Lane 2: Human fetal brain tissue lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 86 kDa
Observed band size: 90 kDa
This data was developed using Anti-HCN3 antibody [EPR13494(2)] ab192025, the same antibody clone in a different buffer formulation.Western blot analysis of HCN3 in Human fetal brain lysate immunoprecipitated using Anti-HCN3 antibody [EPR13494(2)] ab192025 at 1/30 dilution.Secondary antibody: Goat anti-Rabbit IgG (H+L), Peroxidase conjugated at 1/1000 dilution. Blocking/dilution buffer: 5% NFDM/TBST.
All lanes: Immunoprecipitation - Anti-HCN3 antibody [EPR13494(2)] (Anti-HCN3 antibody [EPR13494(2)] ab192025)
Predicted band size: 86 kDa
This data was developed using Anti-HCN3 antibody [EPR13494(2)] ab192025, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-HCN3 antibody [EPR13494(2)] (Anti-HCN3 antibody [EPR13494(2)] ab192025) at 1/1000 dilution
Lane 1: Human forebrain lysate at 10 µg
Lane 2: Human hypothalamus lysate at 10 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 86 kDa
Observed band size: 90 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com